MeSH D013035 - spasm
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Cyclobenzaprine | Amrix | 2023-11-14 | 2007-02-01 |  |  |
| Methocarbamol | Methocarbamol |  | 1982-01-01 |  |  | |
| Aspirin, Methocarbamol | Methocarbamol Aspirin |  | 1982-12-22 |  |  | |
| Novast Laboratories | Tizanidine | Tizanidine |  | 2019-03-12 |  |  |
| Cyclobenzaprine | Cyclobenzaprine |  | 2024-08-27 |  |  | |
| Mylan | Methocarbamol | Methocarbamol |  | 1982-01-01 |  |  |
| Tizanidine | Tizanidine |  | 2012-11-09 |  |  | |
| Johnson & Johnson | Cyclobenzaprine | Flexeril |  | 1982-01-01 |  |  |
| Cipla | Cyclobenzaprine | Cyclobenzaprine |  | 2010-07-23 |  |  |
| Lupin Research | Orphenadrine | Orphenadrine |  | 1998-06-19 |  |  |
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
100%2/2
Phase 2
57%4/7
Phase 3
76%13/17
Approved: 12Overall Success rate: 44%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
8
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use